The approach I use at Mindstream Wellness is grounded in research across several fields: psilocybin-assisted therapy, Acceptance and Commitment Therapy, mindfulness-based interventions, and life coaching outcomes. This page highlights the studies and sources that most directly inform my work — not a comprehensive literature review, but a curated selection of what I think matters most and why.
If you're a therapist or physician evaluating psilocybin facilitation for a client, this is a good place to start understanding the evidence. If you're a potential client who wants to know what the research says, I've included brief context for each entry to help make the science accessible.
Green, Oades & Grant, 2006 — Cognitive-behavioral, solution-focused life coaching: Enhancing goal striving, well-being, and hope
One of the earlier rigorous studies on life coaching outcomes. Participants in a coaching program showed significant increases in goal striving, well-being, and hope compared to controls. The study is notable because it used a non-clinical population — these were people who were functioning well but wanted to move toward something more aligned with their values. That's the population I primarily serve through coaching: not people in crisis (who often need therapy), but people navigating transitions who want structured support for the work of building a life that fits who they're becoming.
Theeboom, Beersma & van Vianen, 2014 — Does coaching work? A meta-analysis on the effects of coaching on individual level outcomes in an organizational context
A meta-analysis of 18 studies finding positive effects of coaching on performance, well-being, coping, work attitudes, and self-regulation. The effect sizes were meaningful across all categories. What the meta-analysis doesn't capture — but what matters for how I work — is that coaching's effectiveness depends heavily on the framework the coach is operating from. A coach using ACT principles is doing fundamentally different work than a coach using a goals-and-accountability model, even if both fall under the "life coaching" umbrella. The research supports coaching as an effective modality; the framework determines what kind of change it produces.
A-Tjak et al., 2015 — A Meta-Analysis of the Efficacy of Acceptance and Commitment Therapy for Clinically Relevant Mental and Physical Health Problems
The most comprehensive meta-analysis of ACT outcomes to date at the time of publication, covering 39 randomized controlled trials. ACT showed efficacy across depression, anxiety, addiction, and chronic pain — with effect sizes comparable to established treatments like CBT. What distinguishes ACT from most therapeutic approaches isn't that it works better for any single condition; it's the breadth. The psychological flexibility model targets processes that cut across diagnostic categories, which is part of why it integrates so well with psilocybin work — both operate on the relationship between the person and their internal experience rather than on specific symptoms.
Hayes, Strosahl & Wilson, 2012 — Acceptance and Commitment Therapy: The Process and Practice of Mindful Change (2nd Edition)
This is the foundational ACT text, and it's worth noting what makes ACT distinctive as a framework: it doesn't aim to reduce or eliminate difficult thoughts and feelings. Instead, it builds psychological flexibility — the ability to be present with whatever is arising internally while still taking action aligned with your values. That capacity is exactly what psilocybin sessions demand. The journey often surfaces difficult material — grief, fear, existential questions — and the relevant skill isn't making those experiences stop. It's staying open to them, observing them without being captured by them, and using what emerges to inform how you want to live. ACT provides the conceptual framework and the practical skills for that process.
For more on how ACT and contemplative practice converge, see my blog post The Mind Watching Itself: Where ACT Meets Buddhist Practice.
Yalom, Irvin D., 1980 — Existential Psychotherapy
The foundational text in the field, and the one that most directly informs how I understand what my clients are facing. Yalom identifies four "ultimate concerns" that underlie human anxiety: death, freedom (and its accompanying groundlessness), isolation, and meaninglessness. These aren't clinical abstractions — they're what surfaces when someone receives a serious diagnosis, loses a person central to their life, faces a transition that strips away their familiar identity, or sits in a psilocybin session as the usual defenses quiet down. Yalom's central insight is that confronting these concerns directly — rather than defending against them — is what makes genuine transformation possible. He calls death a "boundary experience" that can catalyze a radical shift in how a person lives. That framework is the backbone of my end-of-life work, and it shapes how I understand what happens during psilocybin sessions when existential material surfaces.
Breitbart et al., 2010 — Meaning-centered group psychotherapy for patients with advanced cancer: A pilot randomized controlled trial
Breitbart et al., 2015 — Meaning-centered group psychotherapy for patients with advanced cancer: A phase III randomized controlled trial
William Breitbart's group at Memorial Sloan Kettering developed an intervention explicitly grounded in existential concerns — drawing on Viktor Frankl's work on meaning — and tested it in randomized controlled trials with advanced cancer patients. The results showed significant improvements in spiritual well-being, sense of meaning, and reduced hopelessness and desire for hastened death. This is the strongest empirical evidence that addressing existential concerns directly produces measurable clinical benefit, not just philosophical comfort. It also bridges naturally to the psilocybin-for-cancer research from Griffiths: both interventions help people facing mortality not by eliminating fear, but by shifting their relationship to it.
Frankl, Viktor, 1946 — Man's Search for Meaning
Not a research citation, but a foundational source that shapes how I think about what clients are pursuing. Frankl's central argument — forged in the concentration camps of World War II — is that the primary human drive is not toward happiness or pleasure but toward meaning. People can endure extraordinary suffering if they can locate meaning in it; they collapse psychologically when they can't. This distinction between pursuing happiness and pursuing meaning is directly relevant to psilocybin integration work. Clients often arrive expecting that a journey will make them feel better. What it more often provides is clarity about what matters — and an increased capacity to feel everything more fully, including the difficult things. Frankl's framework helps me prepare clients for that reality and helps them make sense of it afterward.
Hofmann et al., 2010 — The Effect of Mindfulness-Based Therapy on Anxiety and Depression: A Meta-Analytic Review
A meta-analysis of 39 studies finding that mindfulness-based therapy significantly reduced anxiety and depressive symptoms across clinical populations. The effect sizes were robust and held across different conditions, including medical populations — which is relevant to my work with clients facing life-altering diagnoses. Mindfulness doesn't eliminate the reality of a difficult situation. What it does — and what the research supports — is change the person's relationship to their experience of that situation. That's the same mechanism that ACT targets and that psilocybin appears to catalyze.
Keng, Smoski & Robins, 2011 — Effects of Mindfulness on Psychological Health: A Review of Empirical Studies
A broad review covering both clinical and non-clinical populations, finding that mindfulness practice is associated with reduced rumination, reduced emotional reactivity, and increased cognitive flexibility. These are the same capacities that prepare someone for a productive psilocybin experience — and the same capacities that integration work aims to strengthen afterward. The convergence isn't coincidental: both mindfulness and psilocybin appear to work in part by disrupting the default mode network's habitual patterns of self-referential thinking.
Gukasyan et al., 2022 — Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up
This is the longest follow-up from the Johns Hopkins psilocybin-for-depression program. Participants who received two psilocybin sessions with psychological support showed sustained reductions in depression at twelve months. What matters here isn't just that it worked — it's that two sessions, with proper preparation and integration, produced effects that lasted a year. That durability is why I structure my work as a multi-session process rather than a single event.
Carhart-Harris et al., 2017 — Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
One of the earlier studies establishing that psilocybin could help people who hadn't responded to conventional antidepressants. The six-month follow-up showed sustained benefit for most participants. Notably, "psychological support" in this context means preparation and integration sessions — not just the dosing session itself. The researchers found that the quality of the subjective experience during the session predicted outcomes, which underscores why set, setting, and skilled facilitation matter as much as the molecule.
Griffiths et al., 2016 — Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
This is the study I reference most often with clients facing serious illness. Participants with life-threatening cancer diagnoses who received a single high-dose psilocybin session showed clinically significant reductions in anxiety and depression — and roughly 80% still showed sustained benefit at six-month follow-up. What the study can't fully capture, but what clinicians involved have described, is the shift in relationship to mortality: not denial, but a kind of acceptance that reduced the existential terror without requiring the person to pretend everything was fine. The resonance with Breitbart's meaning-centered work above is not coincidental — both approaches help people facing death by engaging with existential reality rather than defending against it.
Johnson et al., 2014 — Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
This small pilot study showed an 80% abstinence rate at six months for long-term smokers who received psilocybin-assisted therapy — dramatically higher than any existing pharmacological treatment. What's interesting from a mechanistic standpoint is that psilocybin doesn't work on nicotine receptors at all. The researchers hypothesized that it works by disrupting deeply entrenched patterns of self-referential thinking — the stories people tell themselves about who they are and what they can or can't change. That mechanism is consistent with what we see in ACT: the issue often isn't the behavior itself, but the psychological inflexibility that maintains it.
Smigielski et al., 2019 — Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity
This is the study that most directly supports combining meditation practice with psilocybin — the core design principle of my Liberation Intensive program. Researchers found that psilocybin combined with a structured meditation retreat produced changes in self-referential processing and default mode network connectivity that neither intervention produced as reliably on its own. In practical terms: meditation builds the attentional skills that allow someone to engage with the psilocybin experience more productively, and psilocybin appears to deepen and accelerate the kinds of shifts in self-perception that meditation cultivates over longer periods.
Heuschkel & Grautoff, 2020 — Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression
A thorough review arguing that meditation and psilocybin share overlapping mechanisms — both quiet the default mode network, both reduce rigid self-referential thinking, and both can produce experiences of ego dissolution that shift how people relate to their own thoughts. The authors propose that the two could potentiate each other's effects. This is consistent with what I observe in practice: clients with even basic mindfulness skills tend to navigate psilocybin experiences with more openness and less reactivity, and the psilocybin experience often motivates a more committed meditation practice afterward.
Madsen et al., 2020 — Psilocybin dose is associated with long-term increases in mindfulness
A dose-response finding: higher psilocybin doses were associated with greater long-term increases in trait mindfulness. This matters because mindfulness isn't just a pleasant state — it's a measurable capacity that correlates with psychological flexibility, reduced rumination, and better emotional regulation. The finding suggests that psilocybin doesn't just produce temporary experiences of expanded awareness; it may durably increase the capacity for the kind of present-moment attention that meditation traditions have cultivated for millennia.
For a deeper discussion of how these two practices inform each other, see my blog post Compass and Vehicle: How Meditation and Psilocybin Inform Each Other.
This is the evidence review that informed Oregon's Measure 109 implementation — the legal framework under which I practice. The review concluded that high-quality clinical trials suggest psilocybin is efficacious in reducing depression and anxiety, including in life-threatening conditions, with large effect sizes. It also noted that in all trials, psilocybin was administered in the context of counseling support before and after dosing — not as a standalone intervention. Oregon's requirement for facilitated sessions reflects this research finding: the molecule alone isn't the treatment. The treatment is the molecule within a structured, supported process.
Psilocybin research is promising but still evolving. Most studies to date have been relatively small, with limited participant diversity, and the field is still working out optimal protocols, dosing, and long-term outcomes. I take the science seriously — it informs how I work — but I don't overstate it. What the evidence currently supports is that psilocybin, administered with proper preparation and integration support, can produce meaningful and durable psychological shifts for many people. It does not support the idea that psilocybin is a cure-all, and it doesn't replace the need for individualized assessment of whether this work is appropriate for a given person.
I update this page as significant new research emerges.
For a detailed explanation of the neuroscience underlying my three-phase approach, see Three Phases, Three Mechanisms: The Thinking Behind the Mindstream Wellness Protocol.